Dear Clinical Team, We Have Just Two Words For You: Thank You.

When we look back at the key people that kept the world turning during these past difficult times, it’s a must that we pay our thanks to those behind the scenes who continued in their quests to enable drug development and to safely and accurately help bring drugs to market in the quickest possible way.

Displaying true professionalism day in and day out, the teams leading clinical trials here at QUINTA-ANALYTICA are an integral part of the pharma industry and have pushed harder than ever these past two years, adapting quickly to a constantly changing situation in order to keep volunteers safe and well cared for, and ensuring that trials continued operating for the advancement of new medicines.

Times may have been tough, but where there’s a will, there’s a way and the clinical team certainly epitomize this. So thank you, from all at Quinta!

To learn more about Quintas’ A-Z of services including more about the trials conducted in their own in-house facility get in touch with us today.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.